Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC9 | O60706 | 9/20 | 1.00 |
| ▸ | ABCC8 | Q09428 | 2/20 | 1.00 |
| ▸ | KCNJ11 | Q14654 | 2/20 | 1.00 |
| ▸ | KCNJ8 | Q15842 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 8/20 | 0.55 |
| ▸ | PDE4A | P27815 | 1/20 | 0.53 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.53 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.53 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Levcromakalim SCHEMBL122344 | 1.00 | ABCC9 (1.00) | ABCC9ABCC8KCNJ11KCNJ8CYP1A2 | |
| (-)-Cromakalim SCHEMBL10644663 | 1.00 | ABCC9 (1.00) | ABCC9ABCC8KCNJ11KCNJ8CYP1A2 | |
| Levcromakalim SCHEMBL30059152 | 1.00 | ABCC9 (1.00) | ABCC9ABCC8KCNJ11KCNJ8CYP1A2 | |
| (-)-Cromakalim SCHEMBL24658941 | 1.00 | ABCC9 (1.00) | ABCC9ABCC8KCNJ11KCNJ8CYP1A2 | |
| Cromakalim SCHEMBL3312760 | 1.00 | ABCC9 (1.00) | ABCC9ABCC8KCNJ11KCNJ8CYP1A2 | |
| (-)-Cromakalim SCHEMBL25029865 | 1.00 | ABCC9 (1.00) | ABCC9ABCC8KCNJ11KCNJ8CYP1A2 | |
| (-)-Cromakalim SCHEMBL3771007 | 1.00 | ABCC9 (1.00) | ABCC9ABCC8KCNJ11KCNJ8CYP1A2 | |
| (-)-Cromakalim SCHEMBL29345689 | 1.00 | ABCC9 (1.00) | ABCC9ABCC8KCNJ11KCNJ8CYP1A2 | |
| Cromakalim SCHEMBL30110320 | 1.00 | ABCC9 (1.00) | ABCC9ABCC8KCNJ11KCNJ8CYP1A2 | |
| SCHEMBL10636063 | 0.97 | ABCC9 (0.94) | ABCC9ABCC8KCNJ11KCNJ8CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3716 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260076961-A1 | COMBINATION TREATMENTS | Celex Oncology Innovations Limited (GB) | 2026-03-19 | — | — | US | claimed |
| WO-2025078664-A1 | TREATMENT OF METASTATIC OR INVASIVE BRAIN CANCER | Celex Oncology Innovations Limited (GB) | 2025-04-17 | — | — | WO | claimed |
| WO-2025064646-A1 | COMPOSITIONS AND METHODS FOR WOUND HEALING AND HAIR GROWTH USING POLYELECTROLYTE COMPLEX (PEC) FILMS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2025-03-27 | — | — | WO | claimed |
| EP-4486338-A2 | TOPICAL OCULAR DELIVERY OF CROMAKALIM | Qlaris Bio, Inc. (US) | 2025-01-08 | — | — | EP | claimed |
| US-20240299405-A1 | APPLICATION OF ATP POTASSIUM CHANNEL MODIFIER IN PREPARATION OF ANTI-DIABETIC NEPHROPATHY DRUG | HANGZHOU QIAN BIOTECHNOLOGY LTD (CN) | 2024-09-12 | — | — | US | claimed |
| US-20240285580-A1 | COMPOSITIONS AND METHODS FOR EXTENDED RELEASE CROMAKALIM THERAPY | QLARIS BIO, INC. (US) | 2024-08-29 | — | — | US | claimed |
| EP-4384162-A1 | COMPOSITIONS AND METHODS FOR EXTENDED RELEASE CROMAKALIM THERAPY | Qlaris Bio, Inc. (US) | 2024-06-19 | — | — | EP | claimed |
| WO-2024098043-A2 | TOPICAL OCULAR DELIVERY OF CROMAKALIM | QLARIS BIO, INC. (US) | 2024-05-10 | — | — | WO | claimed |
| US-20240100123-A1 | NOVEL AIMP1 PROTEIN FRAGMENT AND HAIR GROWTH-PROMOTING COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT | CUREBIO THERAPEUTICS (KR) | 2024-03-28 | — | — | US | claimed |
| US-11872263-B2 | AIMP1 protein fragment and hair growth-promoting composition containing same as active ingredient | CUREBIO THERAPEUTICS (KR) | 2024-01-16 | — | — | US | claimed |
| WO-1988000822-A1 | METHODS, COMPOSITIONS AND SOLUTIONS FOR TREATING ALOPECIA | THE UPJOHN COMPANY (US) | 1988-02-11 | — | — | WO | claimed |
| US-4719228-A | Pharmaceutical composition | Rawlins, David A. (GB) | 1988-01-12 | — | — | US | claimed |
| EP-0207614-A2 | Benzopyran compounds in the treatment of incontinence | BEECHAM GROUP PLC (GB) | 1987-01-07 | — | — | EP | claimed |
| EP-0076075-B1 | PHARMACEUTICALLY ACTIVE BENZOPYRAN COMPOUNDS | BEECHAM GROUP PLC (GB) | 1986-11-20 | — | — | EP | claimed |
| EP-0176689-A2 | Benzopyran compounds for the treatment of smooth muscles contraction | BEECHAM GROUP PLC (GB) | 1986-04-09 | — | — | EP | claimed |
| EP-0173848-A2 | Benzopyran compounds for use in the cardiovascular system | BEECHAM GROUP PLC (GB) | 1986-03-12 | — | — | EP | claimed |
| EP-0163178-A2 | Pharmaceutical composition | BEECHAM GROUP PLC (GB) | 1985-12-04 | — | — | EP | claimed |
| EP-0120428-A1 | Benzopyran isomers | BEECHAM GROUP PLC (GB) | 1984-10-03 | — | — | EP | claimed |
| US-4446113-A | HYPOTENSIVE AGENTS | BEECHAM GROUP P.L.C. (GB) | 1984-05-01 | — | — | US | claimed |
| EP-0076075-A1 | Pharmaceutically active benzopyran compounds | BEECHAM GROUP PLC (GB) | 1983-04-06 | — | — | EP | claimed |